Meta-Flux
Techstars '24Dublin, IE · Founded 2021 · 6 employees on LinkedIn · 1 known investors
Meta-Flux builds in silico simulation software that models disease biology — cellular state, perturbation response, and therapeutic intervention — using mechanistic models grounded in public reference atlases and proprietary multi-omic data from partner biobanks. The platform targets drug discovery in neurodegeneration (Parkinson's, Alzheimer's, ALS, MSA) and immuno-oncology (breast, lung, melanoma, colorectal) to improve target selection and patient stratification.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundOct 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 1
by search overlapCompanies competing with Meta-Flux for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Meta-Flux do?
- Meta-Flux builds in silico simulation software that models disease biology — cellular state, perturbation response, and therapeutic intervention — using mechanistic models grounded in public reference atlases and proprietary multi-omic data from partner biobanks. The platform targets drug discovery in neurodegeneration (Parkinson's, Alzheimer's, ALS, MSA) and immuno-oncology (breast, lung, melanoma, colorectal) to improve target selection and patient stratification.
- Who are Meta-Flux's investors?
- Meta-Flux's investors include Techstars.
- Where is Meta-Flux headquartered?
- Meta-Flux is headquartered in Dublin, IE.